AIM
PETX

Artemis Investment Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Artemis Investment Management’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,024
Closed -$401K – 297
2015
Q1 		$401K Buy
+25,024
New +$445K 0.02% 223

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artemis Investment Management's PETX Position: Q2 2015 in Review

Artemis Investment Management sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2015, closing a stake of 25,024 shares — an estimated $401K sold.

Artemis Investment Management first reported a position in PETX in Q1 2015 and held it in 1 quarter. The position peaked at $401K in Q1 2015. 92 funds tracked by Wall St. Rank hold PETX as of Q2 2015.

  • Artemis Investment Management reported no remaining Aratana Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Artemis Investment Management sold 25,024 Aratana Therapeutics, Inc. shares in Q2 2015, an estimated $401K.
  • Artemis Investment Management first reported a position in Aratana Therapeutics, Inc. in Q1 2015 and held it in 1 quarter.
  • Artemis Investment Management's Aratana Therapeutics, Inc. position peaked at $401K in Q1 2015.
  • 92 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2015.

Based on Artemis Investment Management's 13F filing for Q2 2015, filed 29 Jul 2015.